Historical shareholding details of BlackRock Global Equity Market Neutral holdings in Halozyme Therapeutics Inc. (HALO)

Monthly changes of BlackRock Global Equity Market Neutral shareholding in Halozyme Therapeutics Inc. over the previous months

Month Name Total no. shares held Percent Holding
May 31, 2025 Blackrock Global Equity Market Neutral 29,800 0.02%
Apr 30, 2025 Blackrock Global Equity Market Neutral 6,549 0.01%
Oct 31, 2024 Blackrock Global Equity Market Neutral 0 0.00%
Sep 30, 2024 Blackrock Global Equity Market Neutral 57,564 0.05%
Aug 31, 2024 Blackrock Global Equity Market Neutral 62,590 0.05%
Jul 31, 2024 Blackrock Global Equity Market Neutral 69,435 0.05%
Jun 30, 2024 Blackrock Global Equity Market Neutral 69,435 0.05%
May 31, 2024 Blackrock Global Equity Market Neutral 69,650 0.05%
Apr 30, 2024 Blackrock Global Equity Market Neutral 64,765 0.05%
Mar 31, 2024 Blackrock Global Equity Market Neutral 55,074 0.04%
Feb 29, 2024 Blackrock Global Equity Market Neutral 44,356 0.03%
Jan 31, 2024 Blackrock Global Equity Market Neutral 41,106 0.03%
Dec 31, 2023 Blackrock Global Equity Market Neutral 31,464 0.02%
Nov 30, 2023 Blackrock Global Equity Market Neutral 31,464 0.02%
Oct 31, 2023 Blackrock Global Equity Market Neutral 32,168 0.02%
Sep 30, 2023 Blackrock Global Equity Market Neutral 32,168 0.02%
Aug 31, 2023 Blackrock Global Equity Market Neutral 32,168 0.02%
Jul 31, 2023 Blackrock Global Equity Market Neutral 28,226 0.02%
Jun 30, 2023 Blackrock Global Equity Market Neutral 15,606 0.01%
May 31, 2023 Blackrock Global Equity Market Neutral 14,261 0.01%
Apr 30, 2023 Blackrock Global Equity Market Neutral 14,261 0.01%

View all ownership details of Halozyme Therapeutics Inc.